Arch Biopartners Releases Inflammatory Enzymes, Bowel Disease Study

Arch Biopartners has announced the release of a study linking the caspase 1 enzyme to inflammatory bowel disease that was published in the Inflammatory Bowel Diseases journal.

Advertisement

Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

The full “Epithelial Cell Extrusion Leads to Breaches in the Intestinal Epithelium” study can be found here.

Arch Biopartners is a Toronto, Ontario-based technology company.

More Articles on Gastroenterology:
Apollo Endosurgery Receives CE Mark for Endoscopic Suturing Device
UW Health Opens $21M Digestive Center in Madison
Colon Cancer Challenge Foundation, Physicians Endoscopy Partner

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.